KMID : 0311120220630070632
|
|
Yonsei Medical Journal 2022 Volume.63 No. 7 p.632 ~ p.639
|
|
Effects of Interleukin-17A on the Early Stages of Arterial Thrombosis in Mice
|
|
Park Young-Seon
Shim Ye-Seul Kwon Il Lee Heow-Won Nam Hyo-Suk Choi Hyun-Jung Heo Ji-Hoe
|
|
Abstract
|
|
|
Purpose: Interleukin (IL)-17A has been suggested to play a role in the growth and organization of thrombi. We examined whetherIL-17A plays a role in the early stages of thrombosis and whether there are sex differences in the effects of IL-17A.
Materials and Methods: We performed a blinded, randomized, placebo-controlled study to compare time to thrombotic occlu sion and sex differences therein between mice treated with IL-17A and those treated with saline using a ferric chloride-inducedmodel. We also assessed thrombus histology, blood coagulation, and plasma levels of coagulation factors.
Results: Time to occlusion values did not differ between the IL-17A group and the control group (94.6¡¾86.9 sec vs. 121.0¡¾84.4 sec,p=0.238). However, it was significantly shorter in the IL-17A group of female mice (74.6¡¾57.2 sec vs. 130.0¡¾76.2 sec, p=0.032). Inrotational thromboelastometry, the IL-17A group exhibited increased maximum clot firmness (71.3¡¾4.5 mm vs. 66.7¡¾4.7 mm,p=0.038) and greater amplitude at 30 min (69.7¡¾5.2 mm vs. 64.5¡¾5.3 mm, p=0.040) than the control group. In Western blotting,the IL-17A group showed higher levels of coagulation factor XIII (2.2¡¾1.5 vs. 1.0¡¾0.9, p=0.008), monocyte chemoattractant pro tein-1 (1.6¡¾0.6 vs. 1.0¡¾0.4, p=0.023), and tissue factor (1.5¡¾0.6 vs. 1.0¡¾0.5, p=0.003).
Conclusion: IL-17A plays a role in the initial st ages of arterial thrombosis in mice. Coagulation factors and monocyte chemoat tractant protein-1 may be associated with IL-17A-mediated thrombosis.
|
|
KEYWORD
|
|
Thrombosis, interleukin-17A, inflammation, monocyte chemoattractant protein-1, tissue factor, factor XIII
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|